0000899243-20-017299.txt : 20200619
0000899243-20-017299.hdr.sgml : 20200619
20200619200200
ACCESSION NUMBER: 0000899243-20-017299
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190515
FILED AS OF DATE: 20200619
DATE AS OF CHANGE: 20200619
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knappertz Volker
CENTRAL INDEX KEY: 0001754122
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35892
FILM NUMBER: 20976992
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE, VISION PARK, HISTON
CITY: CAMBRIDGE
STATE: X0
ZIP: CB249BZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001351288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
BUSINESS PHONE: 44 1223 266800
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-15
0
0001351288
GW PHARMACEUTICALS PLC
GWPH
0001754122
Knappertz Volker
SOVEREIGN HOUSE, VISION PARK, HISTON
CAMBRIDGE
X0
CB24 9BZ
UNITED KINGDOM
0
1
0
0
Chief Medical Officer
Ordinary Shares
2019-05-15
4
S
0
4296
14.63
D
77940
D
Ordinary Shares
2020-06-17
4
S
0
18000
10.35
D
59940
D
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2019. Inadvertent late filing.
Represented by American Depositary Shares of the Issuer ("ADSs"). Each ADS represents twelve ordinary shares of the Issuer.
The price reported in Column 4 is a price per ordinary share converted from price per ADS.
Due to an administrative error, the Reporting Person's Form 3 filed with the SEC on October 1, 2018 overstated the Reporting Person's ownership of the Issuer's ordinary shares by 4,440 shares (370 ADSs). These shares have been excluded from Column 5.
Also reflects an adjustment to total holdings to exclude twelve shares incorrectly included in prior reports.
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2020.
/s/ Volker Knappertz
2020-06-19